Aimei Health Technology Co., Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Aimei Health Technology
Blank Checks, SIC 6770
Aimei Health Technology Co., Ltd. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating entities. The organization focuses primarily on targeting small-cap businesses within the healthcare landscape, specifically across the biopharmaceutical, medical technology, medical device, and diagnostic or related services sectors. As an acquisition vehicle, it does not manufacture commercial products or deliver consumer services directly to clients or end customers.
The company is incorporated in the Cayman Islands as an exempted company and maintains its principal executive offices in New York, New York. Its operational reach and search efforts for identifying potential business combination candidates are not restricted to any particular geographic location.
Summary of the business section of Aimei Health Technology's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Aimei Health Technology Co., Ltd.
- Founded
- 2023
- Headquarters
- New York, NY
- Address
- 10 East 53rd Street, Suite 3001 10022
- Phone
- 34 678 035200
- Industry
- Blank Checks
- Fiscal year ends
- December 31
- Auditor
- MaloneBailey, LLP, Houston, Texas
Stock & identifiers
- Ticker
- AFJK
- Other tickers
- AFJKR, AFJKU
- Exchange
- Nasdaq
- IPO date
- Dec 5, 2023
- Shares outstanding
- 3M, Aug 13, 2026
- Public float
- $44.55M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1979005
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Daniel Veikko Polvi | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 25, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 20, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 21, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 1, 2026 | Late filing | Notification of late filing |
| Nov 14, 2025 | Late filing | Notification of late filing |
| Dec 5, 2023 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 30, 2023 | Listing | Registration of securities on an exchange (Form 8-A) |